A citation-based method for searching scientific literature

Maria C Katapodi, Miyeon Jung, Ann M Schafenacker, Kara J Milliron, Kari E Mendelsohn-Victor, Sofia D Merajver, Laurel L Northouse. JMIR Cancer 2018
Times Cited: 10







List of co-cited articles
49 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.
Maria C Katapodi, Laurel L Northouse, Kara J Milliron, Guipeng Liu, Sofia D Merajver. Psychooncology 2013
14
30

Randomized Trial of Telegenetics vs. In-Person Cancer Genetic Counseling: Cost, Patient Satisfaction and Attendance.
Adam H Buchanan, Santanu K Datta, Celette Sugg Skinner, Gail P Hollowell, Henry F Beresford, Thomas Freeland, Benjamin Rogers, John Boling, P Kelly Marcom, Martha B Adams. J Genet Couns 2015
78
30

A Pilot study of the Sharing Risk Information Tool (ShaRIT) for Families with Hereditary Breast and Ovarian Cancer Syndrome.
Ani Kardashian, Julia Fehniger, Jennifer Creasman, Eleanor Cheung, Mary Stanley Beattie. Hered Cancer Clin Pract 2012
21
30

The KinFact intervention - a randomized controlled trial to increase family communication about cancer history.
Joann N Bodurtha, Donna McClish, Maria Gyure, Rosalie Corona, Alexander H Krist, Vivian M Rodríguez, Alisa M Maibauer, Joseph Borzelleca, Deborah J Bowen, John M Quillin. J Womens Health (Larchmt) 2014
20
30

Population screening for genetic disorders in the 21st century: evidence, economics, and ethics.
S D Grosse, W H Rogowski, L F Ross, M C Cornel, W J Dondorp, M J Khoury. Public Health Genomics 2010
83
30

The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.
Fred H Menko, Jacqueline A Ter Stege, Lizet E van der Kolk, Kiki N Jeanson, Winnie Schats, Daoud Ait Moha, Eveline M A Bleiker. Fam Cancer 2019
37
30

A tailored Web-based psychoeducational intervention for cancer patients and their family caregivers.
Laurel Northouse, Ann Schafenacker, Kathryn L C Barr, Maria Katapodi, Hyojin Yoon, Kelly Brittain, Lixin Song, David L Ronis, Larry An. Cancer Nurs 2014
69
20

Recruiting families at risk for hereditary breast and ovarian cancer from a statewide cancer registry: a methodological study.
Maria C Katapodi, Deb Duquette, James J Yang, Kari Mendelsohn-Victor, Beth Anderson, Christos Nikolaidis, Emily Mancewicz, Laurel L Northouse, Sonia Duffy, David Ronis,[...]. Cancer Causes Control 2017
14
20

Underestimation of breast cancer risk: influence on screening behavior.
Maria C Katapodi, Marylin J Dodd, Kathryn A Lee, Noreen C Facione. Oncol Nurs Forum 2009
48
20

Barriers and facilitators for utilization of genetic counseling and risk assessment services in young female breast cancer survivors.
Beth Anderson, Jennifer McLosky, Elizabeth Wasilevich, Sarah Lyon-Callo, Debra Duquette, Glenn Copeland. J Cancer Epidemiol 2012
61
20

The influence of social support on breast cancer screening in a multicultural community sample.
Maria C Katapodi, Noreen C Facione, Christine Miaskowski, Marilyn J Dodd, Catherine Waters. Oncol Nurs Forum 2002
73
20



Development and psychometric testing of a breast cancer survivor self-efficacy scale.
Victoria L Champion, Kim W Ziner, Patrick O Monahan, Timothy E Stump, David Cella, Lisa G Smith, Cynthia J Bell, Diane Von Ah, George W Sledge. Oncol Nurs Forum 2013
18
20

National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
Christopher P Childers, Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko. J Clin Oncol 2017
130
20

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?
Peter D Beitsch, Pat W Whitworth, Kevin Hughes, Rakesh Patel, Barry Rosen, Gia Compagnoni, Paul Baron, Rache Simmons, Linda Ann Smith, Ian Grady,[...]. J Clin Oncol 2019
110
20

Exome Sequencing-Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants.
Kandamurugu Manickam, Adam H Buchanan, Marci L B Schwartz, Miranda L G Hallquist, Janet L Williams, Alanna Kulchak Rahm, Heather Rocha, Juliann M Savatt, Alyson E Evans, Loren M Butry,[...]. JAMA Netw Open 2018
75
20

Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants.
Adam H Buchanan, Kandamurugu Manickam, Michelle N Meyer, Jennifer K Wagner, Miranda L G Hallquist, Janet L Williams, Alanna Kulchak Rahm, Marc S Williams, Zong-Ming E Chen, Chaitali K Shah,[...]. Genet Med 2018
30
20

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.
Efrat Gabai-Kapara, Amnon Lahad, Bella Kaufman, Eitan Friedman, Shlomo Segev, Paul Renbaum, Rachel Beeri, Moran Gal, Julia Grinshpun-Cohen, Karen Djemal,[...]. Proc Natl Acad Sci U S A 2014
191
20

National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
Kimberly K Childers, Melinda Maggard-Gibbons, James Macinko, Christopher P Childers. JAMA Oncol 2018
21
20

Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.
Megan C Roberts, W David Dotson, Christopher S DeVore, Erica M Bednar, Deborah J Bowen, Theodore G Ganiats, Ridgely Fisk Green, Georgia M Hurst, Alisdair R Philp, Charité N Ricker,[...]. Health Aff (Millwood) 2018
49
20


Cascade Genetic Testing of Relatives for Hereditary Cancer Risk: Results of an Online Initiative.
Jennifer L Caswell-Jin, Anjali D Zimmer, Will Stedden, Kerry E Kingham, Alicia Y Zhou, Allison W Kurian. J Natl Cancer Inst 2019
37
20


Family communication following BRCA1/2 genetic testing: a close look at the process.
Darquise Lafrenière, Karine Bouchard, Béatrice Godard, Jacques Simard, Michel Dorval. J Genet Couns 2013
20
20

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
20


Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.
Maria C Katapodi, Valeria Viassolo, Maria Caiata-Zufferey, Christos Nikolaidis, Rosmarie Bührer-Landolt, Nicole Buerki, Rossella Graffeo, Henrik Csaba Horváth, Christian Kurzeder, Manuela Rabaglio,[...]. JMIR Res Protoc 2017
12
20

Challenges and Opportunities for Cancer Predisposition Cascade Screening for Hereditary Breast and Ovarian Cancer and Lynch Syndrome in Switzerland: Findings from an International Workshop.
Christos Nikolaidis, Chang Ming, Carla Pedrazzani, Tina van der Horst, Andrea Kaiser-Grolimund, Zanfina Ademi, Rosmarie Bührer-Landolt, Nicole Bürki, Maria Caiata-Zufferey, Victoria Champion,[...]. Public Health Genomics 2018
7
28

Family communication, genetic testing and colonoscopy screening in hereditary non-polyposis colon cancer: a qualitative study.
Siobhan McCann, Domhnall MacAuley, Yvonne Barnett, Brendan Bunting, Aoife Bradley, Lisa Jeffers, Patrick J Morrison. Psychooncology 2009
40
20

Characteristics of health information gatherers, disseminators, and blockers within families at risk of hereditary cancer: implications for family health communication interventions.
Laura M Koehly, June A Peters, Regina Kenen, Lindsey M Hoskins, Anne L Ersig, Natalia R Kuhn, Jennifer T Loud, Mark H Greene. Am J Public Health 2009
103
20

How to inform at-risk relatives? Attitudes of 1379 Dutch patients, relatives, and members of the general population.
Lieke Marleen van den Heuvel, Daphne Stemkens, Wendy A G van Zelst-Stams, Floor Willeboordse, Imke Christiaans. J Genet Couns 2020
4
50

Availability and payer coverage of BRCA1/2 tests and gene panels.
Elizabeth Clain, Julia R Trosman, Michael P Douglas, Christine B Weldon, Kathryn A Phillips. Nat Biotechnol 2015
17
20

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
482
20

Preparing individuals to communicate genetic test results to their relatives: report of a randomized control trial.
Susan V Montgomery, Andrea M Barsevick, Brian L Egleston, Ruth Bingler, Karen Ruth, Suzanne M Miller, John Malick, Terrence P Cescon, Mary B Daly. Fam Cancer 2013
44
20

What motivates interest in attending a familial cancer genetics clinic?
L Fraser, S Bramald, C Chapman, C Chu, V Cornelius, F Douglas, A Lucassen, A Nehammer, S Sutton, M Trivella,[...]. Fam Cancer 2003
26
20


Outcomes of a randomised controlled trial of a complex genetic counselling intervention to improve family communication.
Jan Hodgson, Sylvia Metcalfe, Clara Gaff, Susan Donath, Martin B Delatycki, Ingrid Winship, Loane Skene, MaryAnne Aitken, Jane Halliday. Eur J Hum Genet 2016
38
20

Features of Computer-Based Decision Aids: Systematic Review, Thematic Synthesis, and Meta-Analyses.
Ania Syrowatka, Dörthe Krömker, Ari N Meguerditchian, Robyn Tamblyn. J Med Internet Res 2016
43
20


Development of FamilyTalk: an Intervention to Support Communication and Educate Families About Colorectal Cancer Risk.
Deborah J Bowen, Travis Hyams, Mercy Laurino, Timothy Woolley, Stacey Cohen, Kathleen A Leppig, Gail Jarvik. J Cancer Educ 2020
6
33

Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Samantha Greenberg, Saundra S Buys, Sandra L Edwards, Whitney Espinel, Alison Fraser, Amanda Gammon, Brent Hafen, Kimberly A Herget, Wendy Kohlmann, Camille Roundy,[...]. Cancer Med 2019
5
40

Physicians communicating with women at genetic risk of breast and ovarian cancer: Are we in the middle of the ford between contradictory messages and unshared decision making?
Marta Fadda, Pierre O Chappuis, Maria C Katapodi, Olivia Pagani, Christian Monnerat, Véronique Membrez, Sheila Unger, Maria Caiata Zufferey. PLoS One 2020
2
100

Telegenetics use in presymptomatic genetic counselling: patient evaluations on satisfaction and quality of care.
Ellen Otten, Erwin Birnie, Adelita V Ranchor, Irene M van Langen. Eur J Hum Genet 2016
23
20


Research participants' experiences with return of genetic research results and preferences for web-based alternatives.
Jill B Gaieski, Linda Patrick-Miller, Brian L Egleston, Kara N Maxwell, Sarah Walser, Laura DiGiovanni, Jamie Brower, Dominique Fetzer, Amanda Ganzak, Danielle McKenna,[...]. Mol Genet Genomic Med 2019
9
22

ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.
Sapna Syngal, Randall E Brand, James M Church, Francis M Giardiello, Heather L Hampel, Randall W Burt. Am J Gastroenterol 2015
624
20

Telegenetics: an Update on Availability and Use of Telemedicine in Clinical Genetics Service.
Irena Vrečar, Dimitar Hristovski, Borut Peterlin. J Med Syst 2017
26
20

All in the family? Communication of cancer survivors with their families.
Deborah J Bowen, Jennifer L Hay, Julie N Harris-Wai, Hendrika Meischke, Wylie Burke. Fam Cancer 2017
13
20

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Suzanne A Eccles, Eric O Aboagye, Simak Ali, Annie S Anderson, Jo Armes, Fedor Berditchevski, Jeremy P Blaydes, Keith Brennan, Nicola J Brown, Helen E Bryant,[...]. Breast Cancer Res 2013
223
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.